HIPPO: A Global Prospective Study on Inguinal Hernia Surgery

Sponsor
University of Birmingham (Other)
Overall Status
Recruiting
CT.gov ID
NCT05748886
Collaborator
(none)
5,000
1
5.4
922.3

Study Details

Study Description

Brief Summary

The primary aim of the HIPPO study is to identify compliance to audit standards (pre-operative and intraoperative) standards for the repair and management of inguinal hernia.

A prospective, multicentre, cohort study will be delivered by NIHR Unit on Global Surgery globally. Mini-teams of up to five collaborators per data collection period will prospectively collect data over a continuous 28-day period at each participating centre. This will be on consecutive patients undergoing elective and/or emergency primary inguinal hernia surgery, with follow-up to 30 postoperative days.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Inguinal hernia surgery is one of the most common elective operations around the world. It was significantly down-prioritised during the pandemic, with fewer planned procedures and a likely increase in a global backlog. According to the most updated data, there are 74,822 patients waiting for inguinal hernia repair in the United Kingdom's National Health Service (NHS), although the recommended expected waiting time should not exceed 18 weeks. It is likely that other countries face the same problem, although such granular data does not exist. Additionally, while waiting for an elective repair, complications of inguinal hernia might arise and an emergency surgery might be needed. Identifying the scale of the global backlog at a global level will inform policy makers on the best strategies to optimise this elective surgical pathway.

    Different surgical techniques exist, with different mesh and non-mesh techniques being described. The most up-to-date international guidelines recommend Lichenstein as the gold-standard for open repair of inguinal hernias, but a more tailored approach is recommended. The patient, the hernia type, and the surgeon's expertise will influence the choice of surgical technique which leads to a wide variation worldwide. Additionally, in areas where there is a deficit of surgeons, task sharing and task shifting might be implemented. Identification of this practice across the world and the outcomes associated with it will inform future research in this area.

    Finally, as inguinal hernia repair is a very common procedure, it can reflect the global uptake of environmentally sustainable measures in elective surgery. Achieving a net zero health system is only possible if reducing the carbon output from operating theatres is included. Different countries might have different protocols and measures adopted to be environmentally sustainable that could be used in different settings. Understanding the baseline point of these practices is extremely important to inform future studies in this area.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    5000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Global Cohort Study: Hernias, Pathway and Planetary Outcomes for Inguinal Hernia Surgery
    Actual Study Start Date :
    Jan 31, 2023
    Anticipated Primary Completion Date :
    Jun 21, 2023
    Anticipated Study Completion Date :
    Jul 15, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Period 1

    00:00 30th Jan 2023 - 23:59 26th Feb 2023 (+ 30 Day Follow-up)

    Period 2

    00:00 27th Feb 2023 - 23:59 26th Mar 2023 (+ 30 Day Follow-up)

    Period 3

    00:00 27th Mar 2023 - 23:59 23th Apr 2023 (+ 30 Day Follow-up)

    Period 4

    00:00 24th April 2023 - 23:59 21st May 2023 (+ 30 Day Follow-up)

    Outcome Measures

    Primary Outcome Measures

    1. Compliance to audit standards described [A continuous 28-day period]

      Mini-teams of up to five collaborators per data collection period will prospectively collect data on audit standards and confounding factors such as age, sex, BMI, ASA grade

    2. Compliance to audit standards described [A continuous 28-day period]

      Mini-teams of up to five collaborators per data collection period will prospectively collect data on audit standards and confounding factors such as BMI

    3. Compliance to audit standards described [A continuous 28-day period]

      Mini-teams of up to five collaborators per data collection period will prospectively collect data on audit standards and confounding factors such as ASA grade

    Secondary Outcome Measures

    1. Number of patients with a 30-day follow-up [30 days post surgery]

      Considering there is no standard practice regarding if patients are evaluated at 30 days after surgery, whether in person or by phone, we establish to characterise this variation globally. Analysing the number of patients who had a phone follow-up and number of patients who did not have any follow up

    2. 30-day surgical site infection rates [30 days post surgery]

      Surgical site infection is defined at 30 days post-surgery using the Centers for Disease Control (CDC) definition of deep incisional or superficial incisional SSI

    3. 30-day reoperation rates [30 days post surgery]

      Re-operation within 30-days of the index operation

    4. Number of patients re-admitted at 30-days [30 days post surgery]

      This will be related to postoperative complications that might require admission of patients and will be measured as number of patients readmitted at 30 days after surgery.

    5. Number of patients who had a complication at 30 days, measured by Clavien-Dindo classification. [30 days post surgery]

      Adverse post-operative events within the follow-up period (30 days)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Summary: Consecutive patients during the selected study period undergoing elective or emergency primary inguinal hernia repair through any operative approach.

    Inclusion criteria:
    • Age: Paediatric and adult patients

    • Procedure: Primary inguinal hernia repair, where this is the main procedure. For patients with bilateral inguinal hernias, data should be entered only for the larger of the two.

    • Approach: Open groin incision, laparoscopic, laparoscopic assisted, laparoscopic converted, robotic, robotic converted procedures are all eligible. Patients with open incisions other than groin incision (e.g. laparotomy) are excluded.

    • Urgency: Patients undergoing planned (elective) surgery or emergency surgery

    Exclusion Criteria:
    Procedures:
    • Recurrent inguinal hernias

    • Surgeries where inguinal hernia repair is not the main procedure, but performed as an additional procedure (eg patient operated for colon cancer and undergoing inguinal hernia repair during the same operation).

    • If patients are undergoing repair of two different types of hernia they can be included if the inguinal hernia repair is the main operation. (e.g. patient undergoing both inguinal and umbilical hernia repair). However, if the inguinal hernia repair is a secondary procedure to a larger non-inguinal hernia repair, patients should be excluded (e.g patient undergoing both large incisional hernia repair and inguinal hernia repair).

    • Laparoscopic converted to open midline procedures

    • Patients undergoing surgery with intent of repair of inguinal hernia, where no hernia inguinal hernia was identified (e.g. intra-operative findings of adenopathy, femoral hernia, obturator hernia)

    Return to theatre:
    • Each individual patient should only be included in the study once. Patients returning to theatre due to complications following earlier surgery can only be included if their index procedure has not already been included in the HIPPO audit.

    • Patients with bilateral hernias undergoing repair with two separate procedures in two different times, should only be included for the first procedure.

    Data should be collected on consecutive patients operated at each centre during the data collection period. This means that all eligible patients should be included.

    Strategies to identify consecutive eligible patients could include:
    • Daily review of elective theatre lists.

    • Daily review of handover sheets and ward lists.

    • Daily review of theatre logbooks (both elective).

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Birmingham Birmingham United Kingdom

    Sponsors and Collaborators

    • University of Birmingham

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Birmingham
    ClinicalTrials.gov Identifier:
    NCT05748886
    Other Study ID Numbers:
    • HIPPO
    First Posted:
    Mar 1, 2023
    Last Update Posted:
    Mar 1, 2023
    Last Verified:
    Feb 1, 2023

    Study Results

    No Results Posted as of Mar 1, 2023